IDO1 and hepatocellular carcinoma: Previous studies have suggested that IDO contributes to immunotolerance in patients with autoimmune diseases and chronic infections [43, 44], and that IDO expressed by hepatocellular carcinoma-associated fibroblasts could induce NK cell dysfunction in vitro[16].